COVID-19 Vaccine: Critical Questions with Complicated Answers
COVID-19 has caused extensive human casualties with significant economic impacts around the globe, and has imposed new challenges on health systems worldwide. Over the past decade, SARS, Ebola, and Zika also led to significant concerns among the scientific community. Interestingly, the SARS and Zika...
Gespeichert in:
| Veröffentlicht in: | Biomolecules & therapeutics 2021-01, Vol.29 (1), p.1-10 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | kor |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 10 |
|---|---|
| container_issue | 1 |
| container_start_page | 1 |
| container_title | Biomolecules & therapeutics |
| container_volume | 29 |
| creator | Haidere, Mohammad Faisal Ratan, Zubair Ahmed Nowroz, Senjuti Zaman, Sojib Bin Jung, You-Jung Hosseinzadeh, Hassan Cho, Jae Youl |
| description | COVID-19 has caused extensive human casualties with significant economic impacts around the globe, and has imposed new challenges on health systems worldwide. Over the past decade, SARS, Ebola, and Zika also led to significant concerns among the scientific community. Interestingly, the SARS and Zika epidemics ended before vaccine development; however, the scholarly community and the pharmaceutical companies responded very quickly at that time. Similarly, when the genetic sequence of SARSCoV- 2 was revealed, global vaccine companies and scientists have stepped forward to develop a vaccine, triggering a race toward vaccine development that the whole world is relying on. Similarly, an effective and safe vaccine could play a pivotal role in eradicating COVID-19. However, few important questions regarding SARS-CoV-2 vaccine development are explored in this review. |
| format | Article |
| fullrecord | <record><control><sourceid>kiss_kisti</sourceid><recordid>TN_cdi_kisti_ndsl_JAKO202108540579954</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><kiss_id>3845513</kiss_id><sourcerecordid>3845513</sourcerecordid><originalsourceid>FETCH-LOGICAL-k504-49b1ae8ff2ca749678bd9b500265fb6ce22c6728e93c05dc258f7dc7338a6f963</originalsourceid><addsrcrecordid>eNo9jrtqwzAYRkVpoSbJE3TR0lGg269LoYNxb2kDJhCyGlmWqIjjBMsl9O1raOl0hu_wca5QwSkFIqUR16hgVitimTS3aJVzaikIoZXhtECPVb1fPxFm8d55n4bwgKsxTcm7Hm-_Qp7Sacj4kqZPXJ2O534eptDhcsiXMOYluomuz2H1xwXavTzvqjeyqV_XVbkhB6CSSNsyF0yM3DstrdKm7WwLlHIFsVU-cO6V5iZY4Sl0noOJuvNaCONUtEos0P3v7SHNQc3Q5b55Lz9qTjmjBiQFbS3I2bv793JzHtPRjd-NMBKACfEDVQtMSA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>COVID-19 Vaccine: Critical Questions with Complicated Answers</title><source>PubMed Central Open Access</source><source>KoreaMed Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Haidere, Mohammad Faisal ; Ratan, Zubair Ahmed ; Nowroz, Senjuti ; Zaman, Sojib Bin ; Jung, You-Jung ; Hosseinzadeh, Hassan ; Cho, Jae Youl</creator><creatorcontrib>Haidere, Mohammad Faisal ; Ratan, Zubair Ahmed ; Nowroz, Senjuti ; Zaman, Sojib Bin ; Jung, You-Jung ; Hosseinzadeh, Hassan ; Cho, Jae Youl</creatorcontrib><description>COVID-19 has caused extensive human casualties with significant economic impacts around the globe, and has imposed new challenges on health systems worldwide. Over the past decade, SARS, Ebola, and Zika also led to significant concerns among the scientific community. Interestingly, the SARS and Zika epidemics ended before vaccine development; however, the scholarly community and the pharmaceutical companies responded very quickly at that time. Similarly, when the genetic sequence of SARSCoV- 2 was revealed, global vaccine companies and scientists have stepped forward to develop a vaccine, triggering a race toward vaccine development that the whole world is relying on. Similarly, an effective and safe vaccine could play a pivotal role in eradicating COVID-19. However, few important questions regarding SARS-CoV-2 vaccine development are explored in this review.</description><identifier>ISSN: 1976-9148</identifier><identifier>EISSN: 2005-4483</identifier><language>kor</language><publisher>한국응용약물학회</publisher><subject>COVID-19 ; Vaccine ; Vaccine backfires ; Vaccine safety</subject><ispartof>Biomolecules & therapeutics, 2021-01, Vol.29 (1), p.1-10</ispartof><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,782,786,887,4028</link.rule.ids></links><search><creatorcontrib>Haidere, Mohammad Faisal</creatorcontrib><creatorcontrib>Ratan, Zubair Ahmed</creatorcontrib><creatorcontrib>Nowroz, Senjuti</creatorcontrib><creatorcontrib>Zaman, Sojib Bin</creatorcontrib><creatorcontrib>Jung, You-Jung</creatorcontrib><creatorcontrib>Hosseinzadeh, Hassan</creatorcontrib><creatorcontrib>Cho, Jae Youl</creatorcontrib><title>COVID-19 Vaccine: Critical Questions with Complicated Answers</title><title>Biomolecules & therapeutics</title><addtitle>Biomolecules & Therapeutics</addtitle><description>COVID-19 has caused extensive human casualties with significant economic impacts around the globe, and has imposed new challenges on health systems worldwide. Over the past decade, SARS, Ebola, and Zika also led to significant concerns among the scientific community. Interestingly, the SARS and Zika epidemics ended before vaccine development; however, the scholarly community and the pharmaceutical companies responded very quickly at that time. Similarly, when the genetic sequence of SARSCoV- 2 was revealed, global vaccine companies and scientists have stepped forward to develop a vaccine, triggering a race toward vaccine development that the whole world is relying on. Similarly, an effective and safe vaccine could play a pivotal role in eradicating COVID-19. However, few important questions regarding SARS-CoV-2 vaccine development are explored in this review.</description><subject>COVID-19</subject><subject>Vaccine</subject><subject>Vaccine backfires</subject><subject>Vaccine safety</subject><issn>1976-9148</issn><issn>2005-4483</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>JDI</sourceid><recordid>eNo9jrtqwzAYRkVpoSbJE3TR0lGg269LoYNxb2kDJhCyGlmWqIjjBMsl9O1raOl0hu_wca5QwSkFIqUR16hgVitimTS3aJVzaikIoZXhtECPVb1fPxFm8d55n4bwgKsxTcm7Hm-_Qp7Sacj4kqZPXJ2O534eptDhcsiXMOYluomuz2H1xwXavTzvqjeyqV_XVbkhB6CSSNsyF0yM3DstrdKm7WwLlHIFsVU-cO6V5iZY4Sl0noOJuvNaCONUtEos0P3v7SHNQc3Q5b55Lz9qTjmjBiQFbS3I2bv793JzHtPRjd-NMBKACfEDVQtMSA</recordid><startdate>20210101</startdate><enddate>20210101</enddate><creator>Haidere, Mohammad Faisal</creator><creator>Ratan, Zubair Ahmed</creator><creator>Nowroz, Senjuti</creator><creator>Zaman, Sojib Bin</creator><creator>Jung, You-Jung</creator><creator>Hosseinzadeh, Hassan</creator><creator>Cho, Jae Youl</creator><general>한국응용약물학회</general><scope>HZB</scope><scope>Q5X</scope><scope>JDI</scope></search><sort><creationdate>20210101</creationdate><title>COVID-19 Vaccine: Critical Questions with Complicated Answers</title><author>Haidere, Mohammad Faisal ; Ratan, Zubair Ahmed ; Nowroz, Senjuti ; Zaman, Sojib Bin ; Jung, You-Jung ; Hosseinzadeh, Hassan ; Cho, Jae Youl</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-k504-49b1ae8ff2ca749678bd9b500265fb6ce22c6728e93c05dc258f7dc7338a6f963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>kor</language><creationdate>2021</creationdate><topic>COVID-19</topic><topic>Vaccine</topic><topic>Vaccine backfires</topic><topic>Vaccine safety</topic><toplevel>online_resources</toplevel><creatorcontrib>Haidere, Mohammad Faisal</creatorcontrib><creatorcontrib>Ratan, Zubair Ahmed</creatorcontrib><creatorcontrib>Nowroz, Senjuti</creatorcontrib><creatorcontrib>Zaman, Sojib Bin</creatorcontrib><creatorcontrib>Jung, You-Jung</creatorcontrib><creatorcontrib>Hosseinzadeh, Hassan</creatorcontrib><creatorcontrib>Cho, Jae Youl</creatorcontrib><collection>Korea Information Science Society (KISS)</collection><collection>Korean Studies Information Service System (KISS) B-Type</collection><collection>KoreaScience</collection><jtitle>Biomolecules & therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Haidere, Mohammad Faisal</au><au>Ratan, Zubair Ahmed</au><au>Nowroz, Senjuti</au><au>Zaman, Sojib Bin</au><au>Jung, You-Jung</au><au>Hosseinzadeh, Hassan</au><au>Cho, Jae Youl</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>COVID-19 Vaccine: Critical Questions with Complicated Answers</atitle><jtitle>Biomolecules & therapeutics</jtitle><addtitle>Biomolecules & Therapeutics</addtitle><date>2021-01-01</date><risdate>2021</risdate><volume>29</volume><issue>1</issue><spage>1</spage><epage>10</epage><pages>1-10</pages><issn>1976-9148</issn><eissn>2005-4483</eissn><abstract>COVID-19 has caused extensive human casualties with significant economic impacts around the globe, and has imposed new challenges on health systems worldwide. Over the past decade, SARS, Ebola, and Zika also led to significant concerns among the scientific community. Interestingly, the SARS and Zika epidemics ended before vaccine development; however, the scholarly community and the pharmaceutical companies responded very quickly at that time. Similarly, when the genetic sequence of SARSCoV- 2 was revealed, global vaccine companies and scientists have stepped forward to develop a vaccine, triggering a race toward vaccine development that the whole world is relying on. Similarly, an effective and safe vaccine could play a pivotal role in eradicating COVID-19. However, few important questions regarding SARS-CoV-2 vaccine development are explored in this review.</abstract><pub>한국응용약물학회</pub><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1976-9148 |
| ispartof | Biomolecules & therapeutics, 2021-01, Vol.29 (1), p.1-10 |
| issn | 1976-9148 2005-4483 |
| language | kor |
| recordid | cdi_kisti_ndsl_JAKO202108540579954 |
| source | PubMed Central Open Access; KoreaMed Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | COVID-19 Vaccine Vaccine backfires Vaccine safety |
| title | COVID-19 Vaccine: Critical Questions with Complicated Answers |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T09%3A37%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-kiss_kisti&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=COVID-19%20Vaccine:%20Critical%20Questions%20with%20Complicated%20Answers&rft.jtitle=Biomolecules%20&%20therapeutics&rft.au=Haidere,%20Mohammad%20Faisal&rft.date=2021-01-01&rft.volume=29&rft.issue=1&rft.spage=1&rft.epage=10&rft.pages=1-10&rft.issn=1976-9148&rft.eissn=2005-4483&rft_id=info:doi/&rft_dat=%3Ckiss_kisti%3E3845513%3C/kiss_kisti%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_kiss_id=3845513&rfr_iscdi=true |